Kamada Ltd. (KMDA): Company Cash Volume

Kamada - graphic logo of issuer KMDA

Kamada Ltd. (KMDA) delegates the manufacturing of certain drugs and clinical trials to partners, utilizing external marketing to promote its therapies. Current cash reserves reflect a pivot driven by a moderate dependence on US-based research vendors and strict aviation regulations regarding plasma transport. Liquidity trends confirm the stability of reserves, with the metric reaching the level of 0.07.

Company Cash Volume: Kamada Ltd (KMDA) for 07/04/2022 - 11/21/2026

Metric breakdowns and analytics for Kamada (KMDA)

- stock value and consensus price forecast:
- stock exchange capitalization data:
- cash availability and cash flow indicators:
Comprehensive company analysis:Kamada
Signature product of kamada.com

The protected human capital of biochemists at Kamada Ltd. (KMDA) requires stable funding to maintain research momentum. This indicator captures the net balance of highly liquid assets, determining the issuer's ability to minimize current financial risks. In quantitative analysis, such a metric serves as a foundation for seeking alpha by identifying hidden threats to return on equity. The dynamics of cash assets allow an investor to assess the business's real margin of safety.